new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Astrazeneca Ab
Astrazeneca Ab Sodertaije Swedenastex Thereapeutics Ltd
Astrazeneca Ab Global Intellectual Property
Astrazeneca Ab A Sweden Corporation
Astrazeneca Ab publ
Astrazeneca Ab_20100107
Astrazeneca Ab_20100128
Astrazeneca Ab_20100121
Astrazeneca Ab_20100114
  

Astrazeneca Ab patents

Recent patent applications related to Astrazeneca Ab. Astrazeneca Ab is listed as an Agent/Assignee. Note: Astrazeneca Ab may have other listings under different names/spellings. We're not affiliated with Astrazeneca Ab, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Astrazeneca Ab-related inventors




Date Astrazeneca Ab patents (updated weekly) - BOOKMARK this page
05/25/17 new patent  Deuterated isoxazole derivatives and their use as metabotropic glutamate receptor potentiators
05/18/17Method for suppressing glucagon secretion of an sglt2 inhibitor
05/18/17Pharmaceutical depot for n-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
05/04/17Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide
04/20/17Dry powder inhaler
04/20/17Chemical compounds
03/30/17Compounds and methods for inhibiting jak
03/23/17Phenyl and benzodioxinyl substituted indazoles derivatives
03/23/17Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
03/02/17Pharmaceutical composition
03/02/17Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
03/02/17Novel protein kinase b inhibitors - 060
02/02/17Crystalline forms of (s)-4-amino-n-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7h-pyrrolo[2,3-d]pyrimidin-4-yl) piperidine-4-carboxamide
01/05/17Maleate salts of a quinazoline derivative useful as an antiangiogenic agent
12/29/16Chemical compounds
12/22/16Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
11/24/16Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
11/10/16Pharmaceutical compositions comprising azd9291
11/10/16Pharmaceutical compositions comprising azd9291
11/10/16Compounds and uses
11/03/16Therapeutic treatment
09/29/16Nmda antagonist prodrugs
09/22/16Chromenone derivatives
07/07/16Arginase inhibitors and methods of use
06/30/16Compounds and their use as bace inhibitors
06/30/16Chemical process for the synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline
06/23/16Chemical compounds
06/23/16Novel ticagrelor co-crystal
06/02/16Combination treatment of cancer
06/02/161-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4h-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidase
05/19/16Chemical compounds
05/19/16Chemical compounds
05/12/16Quinazoline derivatives as vegf inhibitors
04/28/16Method of treatment
04/21/16Novel compound
03/17/16Chemical compounds
03/03/16Chromenone derivatives
02/11/16Arginase inhibitors and methods of use thereof
02/04/16Pharmaceutical depot for n-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
02/04/16Pharmaceutical composition 271
01/28/16Combination treatment
01/28/16Composition for inhalation
01/07/16Process
12/31/15Combination therapy for the treatment of nosocomial pneumonia
12/31/15Combination therapy for the treatment of nosocomial pneumonia
12/31/15Benzoxazinone amides as mineralocorticoid receptor modulators
11/26/15Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
11/19/15Chemical compounds
11/12/15Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
10/29/15Chemical compounds
10/22/15Novel compounds
10/08/15Crystalline naloxol-peg conjugate
10/01/15Inhibitors of protein kinases
10/01/15Triazolo[4,5-d]pyrimidine compounds for treatment of abdominal aortic aneurysms
09/10/15Melanocortin receptor-specific peptides
08/27/15Bilayer tablet formulations
08/06/15Cyclopropyl amide derivatives
07/30/15Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
07/23/15Compounds and methods for treating bacterial infections
07/02/15Novel protein kinase b inhibitors - 060
06/18/15Cyclopropyl amide derivatives
06/18/15Cyclopropyl amide derivatives
06/18/15Chemical compounds
05/21/15Therapeutic polymeric nanoparticles and methods of making and using same
05/21/15Pharmaceutical product comprising a p38 kinase inhibitor and a second active ingredient
Patent Packs
05/14/15Compounds and their use as bace inhibitors
05/07/15Inhaler 624
04/30/152-(2,4,5-substituted-anilino)pyrimidine compounds
04/09/15Pyrrolo[3,2-d]pyrimidin-4-one derivatives and their use in therapy
03/26/15Crystalline forms of (s)-4-amino-n-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7h-pyrrolo[2,3-d]pyrimidin-4-yl) piperidine-4-carboxamide
03/19/15Solid dosage form comprising proton pump inhibitor and suspension made thereof
03/19/15Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
03/19/15Phenyl and benzodioxinyl substituted indazoles derivatives
03/12/15Beta-lactamase inhibitor compounds
03/12/15Pyrazinone derivatives
02/26/15Gabr-a2 diagnostic
02/19/15Chemical compounds 251
02/05/15Inhibitors of protein kinases
01/22/15Azaindole compounds, synthesis thereof, and methods of using the same
01/22/15Maleate salts of a quinazoline derivative useful as an antiangiogenic agent
Patent Packs
01/08/15Chemical compounds - 759
01/08/15Inhibitors of protein kinases
12/25/14Chemical process for the synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline
12/11/14Process
12/04/14Chemical compounds
11/06/14Combination treatment of cancer
11/06/142-carboxamide-4-piperazinyl-benzofuran derivative
10/02/14Compounds suitable as precursors to compounds that are useful for imaging amyloid deposits
09/25/14Composition for inhalation
09/25/14Mono-fluoro beta-secretase inhibitors
09/11/14Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
09/11/14Coated tablet formulation and method
08/28/14Pharmaceutical formulations containing an sglt2 inhibitor
08/28/14Methods of producing c-aryl glucoside sglt2 inhibitors
08/21/14Crystalline forms of n-[2-[[(2,3-difluorophenyl)methyl]thio]-6--4-pyrimidinyl]-1-azetidinesulfonamide
08/14/14Novel compound
08/07/14Use of myeloperoxidase (mpo) inhibitors or pharmaceutically acceptable salts thereof to treat multiple sysyem atrophy (msa) 938
07/24/14Chemical compounds
07/24/14Compounds and methods for treating bacterial infections
07/10/14Chromenone derivatives
06/26/14Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide
06/12/14Phosphonoxy quinazoline derivatives and their pharmaceutical use
06/05/14Chemical compounds - 759
05/15/14Process for the preparation of benzyl [(3as,4r,6s,6ar)-6-hydroxy-2,2-dimethyltetrahydro-3ah-cyclopenta[d][1,3]dioxol]-4-yl]carbamate and intermediates in the process
05/08/14Chemical compounds 542
05/01/14Therapeutic treatment
05/01/14Quinazoline derivatives as vegf inhibitors
04/10/14Entraining powder in an airflow
03/27/14Inhaler
03/06/14Novel compounds
Social Network Patent Pack
02/13/14Pharmaceutical depot for 5-fluoro-2-[[(1s)-1-(5-fluoro-2-pyridyl)ethyl]amino]-6-[(5-isopropoxy-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile
02/06/14Chromenone derivatives
02/06/14Heterocyclic compounds as ccr2b antagonists
01/30/14Camsylate salt
01/16/14Chemical compounds
01/02/14Inhaler
12/26/13Cyclohexane-1,2'-naphthalene-1',2"-imidazol compounds and their use as bace
12/26/132h-imidazol-4-amine compounds and their use as bace inhibitors
12/26/13Cyclohexane-1,2'-indene-1',2"-imidazol compounds and their use as bace inhibitors
12/26/13Cycloalkyl ether compounds and their use as bace inhibitors
Patent Packs
11/21/13N-acylsulfonamide apoptosis promoters
10/31/13(4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
09/12/13Injectable emulsion of sedative hypnotic agent
09/12/13Melanocortin receptor-specific peptides
09/12/13Injectable emulsion of sedative hypnotic agent
08/29/13Inhaler comprising a base having a plurality of medicament containing sealed cavities
08/29/13Imidazoquinolines with immuno-modulating properties
08/29/13New process for the preparation of aryl substituted olefinic amines
08/08/13Inhaler cap strap
08/08/13Benzothiazoles as ghrelin receptor modulators
08/08/13Process for making a metabotropic glutamate receptor positive allosteric modulator - 874
08/01/13Gabr-a2 diagnostic
08/01/13Pharmaceutical composition 271
07/18/13Therapeutic agents
07/04/13Processes for making cyclopropyl amide derivatives and intermediates associated therewith
06/27/13Azaquinolinone derivatives and uses thereof
06/06/13Compounds and their use as ikach blockers
05/30/13Inhalation device
05/30/13Ethanamine compounds and methods of using the same
05/23/13Pharmaceutical compositions
05/16/13Pyrazine derivatives
05/02/13Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
04/11/13Pyrazolylaminopyridine derivatives useful as kinase inhibitors
03/14/13Inhaler 624
03/07/13(trimethoxyphenylamino) pyrimidinyl formulations
03/07/13Use of myeloperoxidase (mpo) inhibitors or pharmaceutically acceptable salts thereof to treat multiple sysyem atrophy (msa) 938
02/28/132-(2,4,5-substituted-anilino) pyrimidine compounds
02/14/13Co-crystals of a triazolo [4,5-d] pyrimide platelet aggregation inhibitor
02/07/13Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors
01/31/13New method
Patent Packs
01/31/13Quinuclidine derivatives as muscarinic m3 receptor antagonists
01/24/13Novel piperidine derivatives
01/03/13Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists
01/03/13Chemical compounds
01/03/13Quinazoline derivatives
12/27/12Formulation
12/27/12Quinazoline derivatives
11/15/12Benzoimidazole compounds and uses thereof
11/15/12(4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
11/15/12Chemical compounds 785
11/01/12Ethanamine compounds and methods of using the same
10/25/12Novel salt 628
10/25/122-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
10/18/12Compounds suitable as precursors to compounds that are useful for imaging amyloid deposits
10/18/12Chromenone derivatives
10/18/12Heterocyclic compounds as ccr2 antagonists
10/04/12Combination therapy
09/06/12Benzamide compounds useful as histone deacetylase inhibitors
08/30/12Composition for inhalation
08/23/12N-cyclopropyl-3-fluoro-5-[3-[[1-[2-[2- [(2-hydroxethyl)amino] ethoxy]phenyl] cyclopropyl] amino]-2-oxo- 1 (2h)-pyrazinyl]-4-methyl-benzamide, or pharmaceutically acceptable salts thereof and their uses
Social Network Patent Pack
08/16/12Novel heteroaryl substituted benzothiazoles
07/26/12Novel protein kinase b inhibitors - 060
07/12/12Composition 064
07/12/12Novel compounds
06/28/12Compounds and their use as bace inhibitors
06/28/12Compounds and their use as bace inhibitors
06/28/12Novel compounds
06/28/12Quinazoline derivatives
06/14/12Pharmaceutical depot for n-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
06/14/12Pharmaceutical depot for n-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
06/07/12Compounds and their use as ikach blockers
05/31/12Processes for the preparation of optically active intermediates
05/24/12N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof
05/24/12Process for the preparation of cyclopropyl carboxylic acid esters and derivatives
05/17/12Heterocyclic urea derivatives and methods of use thereof
05/17/12Compounds and their use for treatment of amyloid beta-related diseases
05/17/12Chemical compounds
05/10/12Pharmaceutical composition 271
05/03/12Compounds for the treatment of multi-drug resistant bacterial infections
05/03/12Carbamoyl compounds as dgat1 inhibitors 190
Social Network Patent Pack
05/03/122-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
05/03/12Process 738
04/26/12Ethanolamine salt of n- (3-methoxy-5-methylpyrazin-2yl) -2- (4-[1, 3, 4-oxadiazole-2-yl] phenyl) pyridine-3- sulphonamide
04/26/12Process for preparing [1s-[1-alpha, 2-alpha, 3-beta (1s*,2r*) 5-beta]]-3-[7-[2-(3,4-difluorophenyl)-cyclopropylamino]-5-(propylthio)-3h-1,2,3-triazolo [4,5-d] pyrimidin-3-yl]-5-(2-hydroxyethoxy) cyclopentane-1,2-diol and to its intermediates
04/19/122-aza-bicyclo[2.2.1]heptane compounds and uses thereof
04/19/12Novel compounds
03/29/12Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase-3 related disorders such as alzheimer's disease
03/15/12Compounds and their uses 708
03/01/12Breath activated inhaler
02/23/12Melanocortin receptor-specific peptides
02/09/12Chemical compounds
02/09/122-pyridone derivatives as neutrophil elastase inhibitors and their use
02/09/12Compound for the treatment of tuberculosis
02/09/12Crystalline 4-(3-chloro-2-fluoroanilino)-7 methoxy-6-...
02/02/12Chemical compounds
01/26/12Pyrazine derivatives
01/26/122-(piperidin-1-yl)-4-azolyl-thiazole-5-carboxylic acid derivatives against bacterial infections
01/26/12Pharmaceutical depot for 5-fluoro-2-[[(1s)-1-(5-fluoro-2-pyridyl)ethyl]amino]-6-[(5-isopropoxy-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile
01/12/12(3-(4-(aminomethyl)phenoxy or phenylthio)azetidin-1-yl)(5-phenyl-1,3,4-oxadiazol-2-yl)methanone compounds
01/05/12Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors
12/29/11Extended release formulations comprising quetiapine and methods for their manufacture
12/29/11Pharmaceutical compositions
12/29/11Substituted isoindoles
12/22/11Process for the preparation of 1-[5-(3-chloro-phenyl)-isooxazol-3-yl]-ethanone and (r)-1-[5-(3-chloro-phenyl)-isooxazol-3-yl]-ethanol
12/15/11Chemical compounds
12/15/11Processes for the manufacture of 3--pyridine, 4-methyl-3-methylthio-5-(3-pyridyl)-l,2,4-triazole, and (1r)-1-[2-(3-methylphenyl)-2h-tetrazol-5-yl]ethanol
12/01/1116 alpha, 17 alpha-acetal glucocorticosteroidal derivatives and their use
12/01/11A new process for preparing 4-[4-methyl-5-(cl-10alkylthio/c5-10aryl-cl-6alkylthio)-4h-1,2,4-triazol-3-yl]pyridines
11/24/11[4-( 1-amino-ethyl) - cyclohexyl ] - methyl - amines as antibacterials
11/17/11Package
Social Network Patent Pack
11/17/11Hemifumarate salt
11/17/11Phenoxiacetic acid derivatives
10/20/11Inhaler with audible indicator means
10/20/11Chemical process
10/13/11Chemical compounds
10/06/11Pharmaceutical product comprising a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist
09/29/11Quinazoline derivatives as antiproliferative agents
09/15/11Novel crystalline form
09/15/11Crystalline form of 4-(5--4-methyl-4h-1,2,4-triazol-3-yl)pyridine
09/15/11Pyrazole derivatives as 11-beta-hsd1 inhibitors
09/08/11Chemical compounds 251
09/08/11Novel triazolo pyrimidine compounds
09/01/11Combination of zd6474 and pemetrexed
08/25/11Solid forms of 4--n,n-diethylbenzamide, compositions thereof, and uses therewith
08/25/11Use of myeloperoxidase (mpo) inhibitors or pharmaceutically acceptable salts thereof to treat multiple sysyem atrophy (msa) 938
08/04/11Prefilled container insert for mixing two or more ingredients for use in a pharmaceutical container system
08/04/11Chemical compounds
08/04/11Process for the preparation of cyclopropyl carboxylic acid esters and derivatives
07/28/11Tricyclic 2,4-diamino-l,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disorders
07/07/11Pyridine compounds
06/30/11Steroid derivatives acting as glucocorticosteroid receptor agonists
06/30/11Cannabinoid receptor ligands
06/30/11Dibenzothiazepine derivatives and use thereof
06/16/11Method of treating schizophrenia and other disorders
06/16/11Cinnoline compounds for the treatment of anxiety, cognitive and mood disorders
06/09/11Method of treating anxiety disorders
06/09/11Novel compounds
06/09/11Nicotinic acetylcholine receptor ligands 101
06/09/11Heterocyclic compounds as ccr2 antagonists







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Astrazeneca Ab in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Astrazeneca Ab with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';